A phase III trial of semaglutide achieved 63% resolution of MASH without worsening fibrosis
25, 2024 The Lancet, Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression, March 2026 UCHealth, Many people using GLP-1 weight loss drugs may not be eating enough nutritious food, May 19, 2025 UCLA Health, Rapid weight loss can lead to loss of muscle mass, May 1, 2024 University of Colorado, The Underappreciated Benefits of GLP-1 Receptor Agonists, Nov
extended for analogs) GLP-3: Not well characterized Side Effects GLP-1: Nausea (common initially) Vomiting Diarrhea or constipation Reduced appetite Potential pancreatitis (rare) GLP-2: Generally well-tolerated Injection site reactions Abdominal pain or discomfort Nausea (less common than GLP-1) Fluid retention GLP-3: Unknown (no clinical use) Availability GLP-1: Widely available through prescription medications (semaglutide, liraglutide, etc.) and research peptides GLP-2: Available as teduglutide (Gattex/Revestive) by prescription
Springer: Berlin, 1988
I think, of course, with any intervention we review the benefits and side effects, Ng also added
This helps you to consume fewer calories, yet feel more satisfied and full